Pingjiang Gold Mine has a prospecting reserve of 1,000 tons, "looks very beautiful", two consecutive boards illuminate the "family background" of Hunan Gold Corporation | Speed reading announcement
①Regarding the significant breakthrough in exploration news about the Wangu Gold Mine in Pingjiang, Hunan. The Hunan gold corporation has expressed views on the gold grade, gold reserves, feasibility of development, and mineral ownership from this mining area. ② The company stated that the controlling shareholder will ultimately inject the gold resource into the listed company based on the reserves submitted to the Hunan Provincial Department of Natural Resources for review and filing under the "integrated exploration" project of the Wangu mining area.
Clinical results did not meet expectations. Tasly Pharmaceutical Group suspends the eight-year development "marathon" of the new anti-cancer drug | Summary of the announcement.
① Tasly Pharmaceutical Group announced the suspension of the research and development of its anmeimu monoclonal antibody. Since its approval in 2016, the drug has reached the IIb phase of clinical research; ② According to the clinical research results, the efficacy of anmeimu monoclonal antibody did not meet expectations, and other EGFR monoclonal antibody biosimilar drugs face fierce competition; ③ This project also involves Sino Biopharmaceutical's equity participation, with Tasly Pharmaceutical Group and Sino Biopharmaceutical respectively recognizing an impairment loss of 0.162 billion yuan and 14.1448 million yuan in assets.
Trading Halted! Shenzhen Goodix Technology intends to acquire display driver chip assets. The target company had planned for an IPO. | Quick Read Announcement
1. Shenzhen Goodix Technology intends to purchase controlling stake in Yungen Technology, entering the field of display driver chips; 2. Yungen Technology's AMOLED display driver chip sales lead domestically, with previous IPO plans; 3. Shenzhen Goodix Technology's profitability has declined significantly in recent years, seeking to increase revenue is an important task.
The transfer did not reach a deal; it was intended to sell 5% equity of special treat Jiuzhi to yifeng pharmacy chain two years ago, but now it has "blown up" | Quick read of the announcement.
① The major shareholder of Jiuzhitang Co., Ltd., Li Zhenguo, has terminated the stock transfer agreement with yifeng pharmacy chain; ② A representative of yifeng pharmacy chain stated that their commercial cooperation with Jiuzhitang Co., Ltd. will continue, and the yifeng pharmacy chain's acquisition of Jiuzhitang pharmacy two years ago is unaffected; ③ Currently, yifeng pharmacy chain holds 4.99% of the shares in Jiuzhitang Co., Ltd., making it the third largest shareholder after heilongjiang state-owned assets and Li Zhenguo.
tj darentang usd: Planning to sell 13% of the shares of Zhongmei SmithKline, still awaiting approval from the antitrust review | Direct hit on the shareholders' meeting
① Today's tj darentang shareholder meeting approved the proposal to sell a 13% stake in Sino-US Tianjin Schering Pharmaceutical Co., Ltd. (referred to as: Sino-US Schering). The company's chairman, Zhang Mingrui, stated: "Sino-US Schering is an outstanding company, and this stake sale is mainly due to the expiration of the 40-year cooperation period." ② The sale of the stake still requires approval from He Liyang after anti-monopoly review by the State Administration for Market Regulation.
The native hongmong system has expanded to the tablet sector, and the huawei hongmong ecosystem is expected to experience accelerated development.
On the morning of November 21, following the release of smartphones, Huawei's terminal announced on its official social platform that a tablet equipped with the native Hongmeng OS will soon debut at the Mate brand event. This marks Huawei's first expansion of the native Hongmeng OS to the tablet track.